Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

AbbVie (NY: ABBV )

162.93 -1.63 (-0.99%)
Official Closing Price Updated: 7:00 PM EDT, May 21, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 3,645,241
Open 165.37
Bid (Size) 162.79 (2)
Ask (Size) 163.62 (4)
Prev. Close 164.56
Today's Range 162.50 - 165.71
52wk Range 130.96 - 182.89
Shares Outstanding N/A
Dividend Yield 3.63%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
3 S&P 500 Stocks That Have Proven Themselves Recession-Proof
Corrections are a part of investing and investors would be smart to have these three S&P 500 stocks to buy when the inevitable happens. 
Via InvestorPlace
Topics Stocks
Exposures US Equities
1 Wall Street Analyst Thinks AbbVie Stock Is Going to $200. Is It a Buy at Around $165?
Revenue growth during what should be a disastrous patent cliff is encouraging. 
Via The Motley Fool
Topics Intellectual Property
Exposures Intellectual Property

Performance

YTD
+1.95%
+1.95%
1 Month
-2.95%
-2.95%
3 Month
-7.29%
-7.29%
6 Month
+17.80%
+17.80%
1 Year
+12.44%
+12.44%

More News

Read More
Cannabis Meets Prescription Drugs, Steroids And Ketamine In Schedule III: What It Means, Key Stocks To Watch
Via Benzinga
Topics Cannabis
Exposures Cannabis
10 Stocks to Build a Dividend Portfolio With
Via The Motley Fool
AbbVie Is 'Successfully Positioned To Absorb Humira Biosimilar Erosion': Analyst
Via Benzinga
The Analyst Verdict: AbbVie In The Eyes Of 5 Experts
Via Benzinga
$1000 Invested In This Stock 5 Years Ago Would Be Worth $2,000 Today
Via Benzinga
7 Value Stocks to Buy and Hold for a Decade of Dominance
Via InvestorPlace
Wall Street Favorites: 3 Retirement Stocks With Strong Buy Ratings for May 2024
Via InvestorPlace
Topics Retirement
Exposures Pension
Will Pharma And Healthcare Have Competitive Edge In Cannabis Post-Rescheduling? Data Analytics Expert Weighs In
Via Benzinga
Topics Cannabis
Exposures Cannabis
Unpacking the Latest Options Trading Trends in AbbVie
Via Benzinga
3 Magnificent Stocks That Are Passive Income Machines
Via The Motley Fool
(ABBV) - Analyzing AbbVie's Short Interest
Via Benzinga
3 Reasons to Buy AbbVie Stock on the Dip
Via The Motley Fool
$1000 Invested In This Stock 10 Years Ago Would Be Worth $3,100 Today
Via Benzinga
What Is the Dividend Payout for AbbVie Stock?
Via The Motley Fool
Healthcare And Biotech Investing 101: What You Need To Know.
Via Talk Markets
Topics Stocks
Exposures US Equities
Earn $1000 Every Month From These 3 Stocks
Via The Motley Fool
Want Decades of Passive Income? 3 Stocks to Buy Now and Hold Forever.
Via The Motley Fool
3 Rock-Solid Dividend Stocks That Are Ideal for Retirees
Via The Motley Fool
Biotech Breakthroughs: 7 Stocks Driving the Next Wave in Healthcare
Via InvestorPlace
AbbVie Tracking for New Highs in 2024
Via MarketBeat
Topics Earnings
Exposures Financial
3 Biotech Stocks to Double Your Money in the Next 24 Months
Via InvestorPlace
MarketBeat Week in Review – 4/29 - 5/3
Via MarketBeat
Topics Economy Stocks
Exposures Interest Rates US Equities
7 Safe Haven Stocks That Can Withstand the Market’s Worst Meltdowns
Via InvestorPlace
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.